Synthesis of anilino-monoindolylmaleimides as potent and selective PKCβ inhibitors

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

We report herein synthesis of PKCbeta-selective inhibitors possessing the novel pharmacophore of anilino-monoindolylmaleimide. Several compounds of this series exhibited IC50's as low as 50 nM against human PKCbeta2. One of the most potent compounds, 6l, inhibited PKCbeta1 and PKCbeta2 with IC50 of 21 and 5 nM, respectively, and exhibited selectivity of more than 60-fold in favor of PKCbeta2 relative to other PKC isozymes (PKCalpha, PKCgamma, and PKCepsilon).

Knowledge Graph

Similar Paper

Synthesis of anilino-monoindolylmaleimides as potent and selective PKCβ inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
Bioorganic & Medicinal Chemistry Letters 2003.0
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3
Bioorganic & Medicinal Chemistry Letters 2003.0
Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides
Journal of Medicinal Chemistry 1992.0
2-aryl-indolyl maleimides - novel and potent inhibitors of protein kinase C
Bioorganic & Medicinal Chemistry Letters 1995.0
Design and synthesis of new leads for PKC bisubstrate inhibitors.
Bioorganic & Medicinal Chemistry Letters 1994.0
Novel Indolylindazolylmaleimides as Inhibitors of Protein Kinase C-β:  Synthesis, Biological Activity, and Cardiovascular Safety
Journal of Medicinal Chemistry 2005.0
(S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ
Journal of Medicinal Chemistry 1996.0
Synthesis and protein kinase C inhibitory activities of indane analogs of balanol
Bioorganic & Medicinal Chemistry Letters 1996.0
Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
Journal of Medicinal Chemistry 2009.0